A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

NCT07076095 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Cell Lung Cancer

Interventions

DRUG: IBB0979
DRUG: topotecan hydrochloride for injection

Sponsor

SUNHO（China）BioPharmaceutical CO., Ltd.

Collaborators

[object Object]